Key Market Insights

§  Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes

§  The market features the presence of more than 80 firms across the globe; majority of these stakeholders are emerging players based in North America

§  A larger proportion of the kits available in the cell therapy domain comprise of different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions

§  Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml

§  Predominantly, the cell therapy reagents are intended to be used at discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation

§  The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation

§  In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios

§  Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities

§  We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings

§  Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies

§  Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their products

§  In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy surface; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies

§  A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy media market at an annualized rate of 12%

§  The projected future opportunity for cell therapy consumable providers is expected to be well distributed across different types of end-users and key geographical regions

Table of Contents

1.                     PREFACE

1.1.                  Introduction

1.2.                  Key Market Insights  

1.3.                  Scope of the Report

1.4.                  Research Methodology

1.5.                  Frequently Asked Questions

1.6.                  Chapter Outlines

2.                     EXECUTIVE SUMMARY

3.                     INTRODUCTION

3.1.                  Context and Background

3.2.                  Introduction to Cell Therapies

3.3.                  Comparison of Cell Therapies with Other Biopharmaceuticals

3.4.                  Classification of Cell Therapy Products

3.5.                  Overview of Cell Therapy Development and Manufacturing

3.6.                  Role of Raw Materials in Cell Therapy Development and Manufacturing

3.7.                  Types of Cell Therapy Consumables

3.8.                  Key Challenges Associated with Manufacturing of Cell Therapy Consumables

3.9.                  Future Perspectives

4.                     MARKET LANDSCAPE

4.1.                  Chapter Overview

4.2.                  List of Cell Therapy Kit Providers

4.3.                  List of Cell Therapy Media Providers

4.4.                  List of Cell Therapy Reagent Providers

4.5.                  List of Cell Therapy Extracellular Matrix Providers

5.                     COMPANY COMPETITIVENESS ANALYSIS

5.1.                  Chapter Overview

5.2.                  Key Assumptions and Parameters

5.3.                  Methodology

5.4.                  Cell Therapy Consumables Providers: Company Competitiveness Analysis

5.5.                  Cell Therapy Kits Providers

5.6.                  Cell Therapy Media Providers

5.7.                  Cell Therapy Reagent Providers

5.8.                  Cell Therapy Extracellular Matrix Providers

6.                     BRAND POSITIONING OF KEY INDUSTRY PLAYERS

6.1.                  Chapter Overview

6.2.                  Scope and Methodology

6.3.                  Brand Positioning: STEMCELL Technologies

6.4.                  Brand Positioning: Miltenyi Biotec

6.5.                  Brand Positioning: Thermo Fisher Scientific

6.6.                  Brand Positioning: Takara Bio

6.7.                  Brand Positioning: GeminiBio

7.                     COMPANY PROFILES

7.1.                  Chapter Overview